The Centers for Disease Control and Prevention (CDC) is offering this cooperative agreement grant to continue enhanced national surveillance for human prion diseases in the United States. This grant is for the purpose of maintaining an active surveillance program, like the one conducted by the National Prion Disease Pathology Surveillance Center (NPDPSC) since 1997. Its goal is to monitor potentially emerging human transmissible spongiform encephalopathies (TSEs). The NPDPSC has served as a critical public health resource, evaluating brain tissues and clinical information from suspected cases for two decades. This continued surveillance confirms diagnoses, determines prion disease types, and identifies any new or variant prion diseases within the U.S., ensuring ongoing monitoring of these critical neurological conditions.
Opportunity ID: 334831
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CK22-2202 |
| Funding Opportunity Title: | Continuing Enhanced National Surveillance for Prion Diseases in the United States |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 28, 2022 |
| Last Updated Date: | Jan 28, 2022 |
| Original Closing Date for Applications: | Mar 29, 2022 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Mar 29, 2022 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Apr 28, 2022 |
| Estimated Total Program Funding: | $20,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Private institutions of higher education County governments State governments Independent school districts Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Hospitals, Laboratories and other public and/or private entities may apply. |
Additional Information
| Agency Name: | Centers for Disease Control – NCEZID |
| Description: | The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement program to continue enhanced national surveillance for human prion diseases in the United States. The purpose of the funding is to continue an active surveillance program similar to that conducted by the National Prion Disease Pathology Surveillance Center (NPDPSC) since 1997 to monitor the occurrence of potentially emerging human transmissible spongiform encephalopathies (TSEs) in the United States. In 1997, in collaboration with the American Association of Neuropathologists (AANP), the National Prion Disease Pathology Surveillance Center was established to enhance national CJD surveillance and to make possible laboratory investigation of newly emerging prion diseases. This pathology center, currently located at Case Western Reserve University in Cleveland, Ohio, provided the services of a cutting edge prion disease laboratory, filling a critical public health gap for monitoring prion diseases in humans. Brain tissues and clinical laboratory information on clinically suspected and diagnosed cases of human prion disease have been evaluated at the NPDPSC for approximately 20 years to confirm diagnoses and determine the type of prion disease, including whether the patients had variant CJD or some other possible emerging prion disease in the United States. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Tracey Ponder
TPonder@cdc.gov Email:TPonder@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334831 Full Announcement-Full Announcement -> PUBLISHED Foa_Content_of_CDC-RFA-CK22-2202.pdf
Packages
| Agency Contact Information: | Tracey Ponder TPonder@cdc.gov Email: TPonder@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.084 | CDC-RFA-CK22-2202 | Continuing Enhanced National Surveillance for Prion Diseases in the United States | PKG00271760 | Jan 28, 2022 | Mar 29, 2022 | View |
Package 1
Mandatory forms
334831 SF424_3_0-3.0.pdf
334831 SFLLL_2_0-2.0.pdf
334831 SF424A-1.0.pdf
334831 BudgetNarrativeAttachments_1_2-1.2.pdf
334831 ProjectNarrativeAttachments_1_2-1.2.pdf
334831 Key_Contacts_2_0-2.0.pdf
Optional forms
334831 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
